The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

The Alzheimer’s Foundation of America is offering scholarships of up to $5,000 to college-bound high school seniors affected ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

The Community Foundation for Brevard recently awarded $100,000 to Florida Institute of Technology’s Shaohua Xu, Ph.D., to ...

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant ...

GlobalData epidemiologists forecast a rise in cases in the US from 2.97 million in 2024 to 4.06 million by 2033.

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

Dr. Anelyssa D'Abreu, an associate professor of neurology in UVA's School of Medicine who specializes in geriatric neurology, ...

EXCLUSIVE - Knowing the heartbreaking moment an elderly loved-one needs residential care is a daunting and emotional time.

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion centers.

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially representing a new avenue for treating Alzheimer’s disease.